Shown values refer to:
Cancer diagnosis | Year (descending) | |||
---|---|---|---|---|
2009-2018 | 2010-2019 | 2011-2020 | 2012-2021 | |
All malignancies | 7.67 | 7.58 | 7.58 | 7.58 |
Leukaemias, myeloproliferative and myelodysplastic diseases | 5.75 | 5.75 | 5.67 | 5.58 |
Lymphomas and reticuloendothelial neoplasms | 13.33 | 13.33 | 13.25 | 13.25 |
CNS and miscellaneous intracranial and intraspinal neoplasms | 7.92 | 7.83 | 7.83 | 7.83 |
Neuroblastoma and other peripheral nervous cell tumours | 1.25 | 1.25 | 1.25 | 1.25 |
Retinoblastoma | 1.08 | 1.08 | 1.08 | 1.08 |
Renal tumours | 3.08 | 3.25 | 3.17 | 3.08 |
Hepatic tumours | 1.83 | 1.83 | 1.75 | 1.75 |
Malignant bone tumours | 13.58 | 13.50 | 13.42 | 13.25 |
Soft tissue and other extraosseous sarcomas | 8.42 | 8.33 | 8.33 | 8.42 |
Germ cell tumours, trophoblastic tumours and neoplasms of gonads | 11.58 | 11.92 | 11.67 | 11.83 |
Other malignant epithelial neoplasms and malignant melanomas | 13.75 | 13.75 | 13.75 | 13.83 |
Others and unspecified malignant neoplasms | 3.25 | 3.08 | 3.17 | 4.00 |
The Federal Health Monitoring System 26. Apr 2024